2. Academic Validation
  3. Biaryl Compounds as Dihydroorotate Dehydrogenase Inhibitors for Treating Acute Myelogenous Leukemia (AML)

Biaryl Compounds as Dihydroorotate Dehydrogenase Inhibitors for Treating Acute Myelogenous Leukemia (AML)

  • ACS Med Chem Lett. 2022 Feb 1;13(2):158-159. doi: 10.1021/acsmedchemlett.2c00017.
Ram W Sabnis 1
Affiliations

Affiliation

  • 1 Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
PMID: 35178168 DOI: 10.1021/acsmedchemlett.2c00017
Figures
Products